Acta Bba News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acta bba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acta Bba Today - Breaking & Trending Today

Frontiers | Aspirin Repurposing in Folate-Decorated Nanoparticles: Another Way to Target Breast Cancer

Breast cancer affects more than one million women per year worldwide. Through this study, we develop a nanoparticle-based drug delivery system to target breast cancer cells. Aspirin has been found to inhibit thromboembolic diseases with its tumor-preventing activity. As a consequence, it relieves disease symptoms and severity. Here, mesoporous Silica Nanoparticles (MNP) have been used to deliver Aspirin to the tumor location. MNP-based Aspirin in folic acid (F)-conjugated Polydopamine (MNP-Asp-PD-PG-F) vehicles are prepared for targeted breast cancer therapy. The vehicle hinges on MNP altered with polymer polyethylene glycol (PG), polydopamine (PD), and folic acid (F). The delivery vehicle was studied for in vitro drug release, cytotoxicity and breast cancer cell proliferation. Folic Acid-conjugated drug delivery vehicles let MNPs achieve an elevated targeting efficacy, ideal for cancer therapy. It was also observed that compared to free Aspirin, our drug delivery system (MNP-Asp-PD-PG ....

United States , United Kingdom , Biochem Biophys , Santa Clara , Acta Bba , Noncovalent Functionalization , Nanomed Nanobiotechnol , Tpgs Functionalized Polydopamine , Clinical Research Program , Shanghai Jiao Tong University School Of Medicine , Shanghai Jiao Tong University Scientific , Family Planning Commission , Agilent Technologies , Status Of Research , Aladdin Industrial Co Ltd , American Type Culture Collection , Bio Rad Model , Drug Aspirin , Proliferation Ability , Breast Cancer , Supplementary Material , Technological Innovation Funds , Shanghai Jiao Tong University School , Recent Advances , Stealth Coating , Nanoparticle Drug Delivery ,

Frontiers | Epidemiology and Genetics of Mucopolysaccharidosis Type VI in Russia

Mucopolysaccharidosis VI (MPS VI) is an autosomal recessive lysosomal storage disease caused by mutations in the arylsulfatase B gene (ARSB) and consequent deficient activity of ARSB, a lysosomal enzyme involved in glycosaminoglycan (s) (GAGs) metabolism. Here we present the results study of ARSB DNA analysis in MPS VI patients in the Russian Federation (RF) and other republics of Former Soviet Union. In a cohort of 68 patients (57 families) with MPS VI, a total of 28 different pathogenic alleles were found. The most prevalent nucleotide changes included c.194C>T (Ser65Phe) and c.454C>T (Arg152Trp). Five pathogenic alleles were novel, not previously reported (с.304C>G, c.533A>G, c.941T>C, c.447 456del10, С.990 1003del14). The nucleotide variant c.454C>T (Arg152Trp) was prevalent allele among Slavic Russian patients. The nucleotide variant c.194C>T (Ser65Phe) was found only in MPS VI families from the Republic of Dagestan. Based on the analysis of dry blood spots ....

United Kingdom , Dubrovacko Neretvanska , Moskovskaya Oblast , Chechnya And Ingushetiya , Baden Wüberg , Yaroslavskaya Oblast , Russia General , North Ossetia , Severnaya Osetiya Alaniya , New York , United States , Krasnodarskiy Kray , Kirovskaya Oblast , Nordrhein Westfalen , Russian Federation , Acta Paediatr , Za Zhi , Acta Bba , Kw Kinzleret Al , Zakharova Eyu , Isogene Lab , A Community , Scientific Clinical Institute Of Pediatrics Moscow , Ministry Of Science , British Columbia , Former Soviet ,